18F-choline PET/CT for distant metastases at early stage of prostate cancer recurrence (PSA< 2 ng/ml), when local salvage radiotherapy is intended

被引:0
|
作者
Cimitan, M. [1 ]
Bagatin, E. [1 ]
Bortolus, R. [2 ]
Canzonieri, V. [3 ]
Morassut, S. [4 ]
Borsatti, E. [1 ]
Trovo, M. [2 ]
机构
[1] Natl Canc Inst CRO IRCCS Aviano, Div Nucl Med, Aviano, PN, Italy
[2] Natl Canc Inst CRO IRCCS Aviano, Div Radiotherapy, Aviano, PN, Italy
[3] Natl Canc Inst CRO IRCCS Aviano, Div Pathol, Aviano, PN, Italy
[4] Natl Canc Inst CRO IRCCS Aviano, Div Radiol, Aviano, PN, Italy
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S157 / S157
页数:1
相关论文
共 50 条
  • [21] 18F-Choline PET/MRI On The Therapeutic Approach For Prostate Cancer Patients Treated With Prostatectomy And Rising PSA Below 1 ng/ml
    Garcia, J. R.
    Blanch, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S609 - S609
  • [22] The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients With Early Recurrence after Definitive Therapy with a PSA < 10 ng/ml
    Lengana, Thabo
    Lawal, Ismaheel
    Van Rensburg, Charl Janse
    Mokoala, Kgomotso
    Moshokoa, Evelyn
    Mazibuko, Sfiso
    Van de Wiele, Christophe
    Maes, Alex
    Vorster, Mariza
    Sathekge, Mike Machaba
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (02): : 120 - 129
  • [23] 18F-Choline PET/CT in the Suspicion of Prostate Cancer Recurrence. Our Experience
    Riola-Parada, C.
    Garcia-Talavera, P.
    Villanueva, J.
    Gomez-Caminero, F.
    Achury, C.
    Diaz, L.
    Canadas, J.
    Penaherrera, A.
    Tamayo, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S608 - S609
  • [24] Value of 18F-Choline PET/CT in restaging of prostate cancer patients with biochemical recurrence
    Beheshti, M.
    Wolf, I.
    Steinmayer, M.
    Broinger, G.
    Kirchweger, B.
    Nader, M.
    Loidl, W.
    Hammer, J.
    Langsteger, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S270 - S270
  • [25] Utility of 18F-Choline PET-CT in the biochemical recurrence of prostate cancer.
    Nunez Garcia, A.
    Garcia Vicente, A.
    Soriano Castrejon, A.
    Jimenez Londono, G.
    Pilkington Woll, P.
    Quejigo Garcia, J.
    Bellon Guardia, M.
    Gonzalez Garcia, B.
    Palomar Munoz, A.
    Talavera Rubio, P.
    Cordero Garcia, J.
    Poblete Garcia, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S461 - S462
  • [26] 18F-Choline PET-CT findings in prostate cancer recurrence and treatment modality
    Mohamed Salem, L., Sr.
    Abella Tarazona, A.
    Ibanez Ibanez, M.
    Godoy Bravo, V.
    Reyes Marlesl, R.
    Sime Loayza, I.
    Navarro Fernandez, J.
    Frutos Esteban, L.
    Castellon Sanchez, M.
    Nicolas Ruiz, F.
    Lopez Cubillana, P.
    Lopez Soler, F.
    Lopez Gonzalez, P.
    Porras Martinez, M.
    Claver Valderas, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S338 - S338
  • [27] Oligometastatic prostate cancer detects by 18F-Choline (FCH) Positron Emission Tomography (PET)/Computed Tomography (CT) in patients with PSA levels & 5 ng/mL
    Cuppari, Lea
    Cervino, Anna Rita
    Reccia, Pasquale
    Burei, Marta
    Guttilla, Andrea
    Gardi, Mario
    Agostini, Andrea
    Saladini, Giorgio
    Evangelista, Laura
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [28] 18F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy
    Henrik Kjölhede
    Göran Ahlgren
    Helen Almquist
    Fredrik Liedberg
    Kerstin Lyttkens
    Thomas Ohlsson
    Ola Bratt
    World Journal of Urology, 2015, 33 : 1749 - 1752
  • [29] 18F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy
    Kjolhede, Henrik
    Ahlgren, Goran
    Almquist, Helen
    Liedberg, Fredrik
    Lyttkens, Kerstin
    Ohlsson, Thomas
    Bratt, Ola
    WORLD JOURNAL OF UROLOGY, 2015, 33 (11) : 1749 - 1752
  • [30] Better Prognosis by early Salvage Radiotherapy (PSA <0.2 ng/ml) in PSA-Progression after Prostate Cancer Surgery
    Thamm, R.
    Bartkowiak, D.
    Bottke, D.
    Siegmann, A.
    Boehmer, D.
    Budach, V
    Wiegel, T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 40 - 40